Thyrocare Technologies (BOM:539871) Net Issuance of Preferred Stock : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Thyrocare Technologies's net issuance of preferred for the three months ended in Mar. 2025 was ₹0 Mil. The number is 0, which means that Thyrocare Technologies has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Thyrocare Technologies's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Thyrocare Technologies Net Issuance of Preferred Stock Historical Data

The historical data trend for Thyrocare Technologies's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Net Issuance of Preferred Stock Chart

Thyrocare Technologies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Thyrocare Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Thyrocare Technologies Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Thyrocare Technologies Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (BOM:539871) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

THYROCARE:India

Address

D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines